In most cases, the grind of litigation moves forward under the careful scrutiny of courts and within the applicable rules of civil procedure. Settlement, on the other hand, is often separate and secretive; hammered out after...more
In this issue of Pro Te (Volume 11, No.3), we examine three important topics that are sure to capture your interest.
The Supreme Court’s Bristol-Meyers Squibb decision was met with no small amount of (completely justified)...more
12/5/2018
/ Actual Damages ,
Advertising ,
Bristol-Myers Squibb ,
Bristol-Myers Squibb Co v Superior Court of California - San Francisco County ,
Cosmetics ,
Damage Caps ,
FDA Approval ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Product Labels ,
Wrongful Death
In this issue of Pro Te (Volume 11, No.2), we examine three important topics with practical implications.
In many jurisdictions, the medical judgment of physicians is almost sacrosanct – at least insofar as it is...more
9/21/2018
/ 21st Century Cures Act ,
Dismissal With Prejudice ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Medical Devices ,
New Guidance ,
Patients ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Regulatory Oversight ,
Statute of Limitations